Eli Lilly & Co. (LLY) Tops Q1 EPS by 9c; Reaffirms FY13 Outlook
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,192.14 +1.02%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.66 billion.
Eli Lilly & Co. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Eli Lilly & Co. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Is Treasury selloff a major issue for stock market bulls?
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
